New drugs: tapentadol hydrochloride, tolvaptan, and benzyl alcohol.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, USA.
D000287:Administration, Topical; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use; D019905:Benzyl Alcohol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000075202:Contraindications; D006801:Humans; D007010:Hyponatremia / Q000188:drug therapy; D010373:Lice Infestations / Q000188:drug therapy*; D010374:Pediculus / Q000187:drug effects*; D010636:Phenols / Q000009:adverse effects / Q000627:therapeutic use; D012536:Scalp Dermatoses / Q000188:drug therapy*; D000077432:Tapentadol; D000077602:Tolvaptan
D000701:Analgesics, Opioid; D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines; D010636:Phenols; D000077602:Tolvaptan; D000077432:Tapentadol; D019905:Benzyl Alcohol